- March 15, 2022
- Newsletter
- 617-430-5616
Menu
Brand Name :
Diamox Sequels (DSC)
Synonyms :
acetazolamide
Class :
Anticonvulsants and Carbonic Anhydrase Inhibitors
choline magnesium trisalicylate
Salicylates may enhance the risk of adverse effects of Carbonic Anhydrase Inhibitors
may enhance risk or severity of adverse effects when combined
may diminish the excretion rate of amantadine
may have an increased CNS depression when combined with acetazolamide
may have an increased effect of CNS depression when combined with Acetazolamide
choline magnesium trisalicylate
may have an increasingly adverse effect when combined with carbonic anhydrase inhibitors
It may enhance the effects when combined with methenamine by the pharmacodynamic synergism
it decreases the rate of elimination of pidotimod
carbonic Anhydrase Inhibitors may reduce the rate of excretion of amphetamines
carbonic Anhydrase Inhibitors may reduce the rate of excretion of amphetamines
carbonic Anhydrase Inhibitors may reduce the rate of excretion of amphetamines
may increase the risk of adverse effects of antipsychotic agents
may increase the risk of adverse effects of antipsychotic agents
may increase the risk of adverse effects of antipsychotic agents
may increase the risk of adverse effects of antipsychotic agents
may increase the risk of adverse effects of antipsychotic agents
may increase the risk of adverse effects of antipsychotic agents
may increase the risk of adverse effects of antipsychotic agents
may increase the risk of adverse effects of antipsychotic agents
may increase the risk of adverse effects of antipsychotic agents
may increase the risk of adverse effects of antipsychotic agents
may increase the risk of adverse effects of antipsychotic agents
may increase the risk of adverse effects of antipsychotic agents
may increase the risk of adverse effects of antipsychotic agents
may increase the risk of adverse effects of antipsychotic agents
may increase the risk of adverse effects of antipsychotic agents
may enhance the adverse effect of antipsychotic agents
may enhance the adverse effect of antipsychotic agents
may enhance the adverse effect of antipsychotic agents
may enhance the adverse effect of antipsychotic agents
may enhance the adverse effect of antipsychotic agents
may enhance the adverse effect of antipsychotic agents
may enhance the adverse effect of antipsychotic agents
may enhance the adverse effect of antipsychotic agents
may decrease the rate of excretion of amphetamines
may decrease the rate of excretion of amphetamines
may decrease the rate of excretion of amphetamines
may decrease the rate of excretion of amphetamines
may decrease the rate of excretion of amphetamines
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
it may diminish the metabolism when combined with aripiprazole lauroxil
may enhance the serum concentration when combined with alpha-/beta-agonists
may increase the risk of adverse effect
may increase the risk of adverse effect
may increase the risk of adverse effect
may increase the risk of adverse effect
may increase the risk of adverse effect
acetazolamide: they may increase the toxic effect of sodium bicarbonate
It may enhance the effects when combined with tasimelteon by affecting CYP3A4 metabolism
Reduced cefotiam excretion may occur when acetazolamide is administered concurrently
it may diminish the excretion rate when combined with gadofosveset, resulting in an enhanced serum level
The potential for enhanced CNS depression exists when halazepam is utilized concurrently with acetazolamide
levobupivacaine and acetazolamide could enhance the risk or seriousness of methemoglobinemia
The potential for increased CNS depression risk or seriousness occurs when acetazolamide is used together with pinazepam
When acetazolamide is used together with medazepam, the risk or seriousness of CNS depression is enhanced
The potential for CNS depression may enhanced when acetazolamide is used together with fencamfamin
acetazolamide may intensify paraldehyde's CNS depressant effects
When acetazolamide is used together with niaprazine, the risk or seriousness of CNS depression is enhanced
When acetazolamide is used together with levosulpiride, the risk or seriousness of CNS depression is enhanced
Therapeutic activity decreased of acetazolamide.
it may increase the level of serum concentration of memantine
it may decrease the rate of excretion of amphetamines
it may increase the level of serum concentration of memantine
carbonic Anhydrase Inhibitors may increase the levels of serum concentration of amantadine
carbonic Anhydrase Inhibitors may decrease the levels of serum concentration of lithium
carbonic Anhydrase Inhibitors may increase the risk of adverse effects of metformin
Carbonic Anhydrase Inhibitors may increase the levels of serum concentration of Alpha-/Beta-Agonists
antiseizure agents may diminish the diagnostic effect of metyrapone
it decreases the efficacy of antiseizure agents
carbonic anhydrase inhibitors may enhance the levels of serum concentration of alpha-/beta-agonists
they increase the toxicity of metformin
choline magnesium trisalicylate
may enhance the adverse effect of carbonic anhydrase inhibitors
may diminish the excretion of amphetamines
may decrease the tiopronin excretion rate
- may increase the toxic effect of antipsychotic agents
may enhance the serum concentration of amantadine
may increase the levels of serum concentration
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the toxic effect of Antipsychotic Agents
may increase the hypoglycemic effect of Antidiabetic Agents
it may enhance the severity of dehydration when combined with castor oil
may increase the metabolism of each other when it is combined
they increase the toxicity of saxagliptin/metformin
acetazolamide can enhance the potency or impact of intranasal dihydroergotamine by modulating the metabolism of the hepatic/intestinal enzyme CYP3A4
acetazolamide can impact the hepatic/intestinal enzyme CYP3A4 metabolism, leading to an elevation in the level or potency of intranasal midazolam
Adverse drug reactions:
Frequency Not Defined
Muscle weakness
Hearing dysfunction or tinnitus
Sulfonamide type reactions
Diarrhea
Metallic taste
Nausea
Urticaria
Anorexia
Confusion
Convulsions
Drowsiness
Flaccid paralysis
Malaise
Paresthesias
Photosensitivity
Hematuria
Polyuria
Glycosuria
Vomiting
Hepatic disease
Aplastic anemia
Agranulocytosis
Leukopenia
Thrombocytopenia
Thrombocytopenic purpura
Melena
Acidosis
Electrolyte imbalance
Pregnancy warnings:
Pregnancy category: c
Breastfeeding warnings:
Pregnancy Categories:
Category A: Satisfactory and well-controlled studies show no risk to the fetus in the first trimester or the later trimester.
Category B: No evidence shown of risk to the fetus found in animal reproduction studies, and there are not enough studies on pregnant women
Category C: Adverse effects on the fetus found with evidence in animal reproduction studies and no adequate evidence for a result in humans must take care of potential risks in pregnant women
Category D: There is adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits
Category X: Drugs listed in this category outweigh risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category
Patient Information Leaflet
Generic Name: acetazolamide
Pronounced: a-SEET-a-ZOLE-a-mide
Why do we use acetazolamide?
Acetazolamide is a diuretic drug that belongs to the subclass carbonic anhydrase used to treat glaucoma, congestive heart failure, edema, seizures, and prevent altitude sickness.